A Single LipiFlow^® Thermal Pulsation System Treatment Improves Meibomian Gland Function and Reduces Dry Eye Symptoms for 9 Months

REFERENCES

• Nelson JD, Shimazaki J, Benitez-del-Castillo JM et al. The international workshop on meibomian gland dysfunction: Report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 2011;52:1930–1937.
   PubMed Web of Science ®Google Scholar
• Nichols KK. The international workshop on meibomian gland dysfunction: Introduction. Invest Ophthalmol Vis Sci 2011;52:1917–1921.
   Web of Science ®Google Scholar
• Bron AJ, Yokoi N, Gafney E, Tiffany JM. Predicted phenotypes of dry eye: Proposed consequences of its natural history. Ocul Surf 2009;7:78–92.
   PubMed Web of Science ®Google Scholar
• Nichols KK, Foulks GN, Bron AJ et al. The international workshop on meibomian gland dysfunction: Executive summary. Invest Ophthalmol Vis Sci 2011;52:1922–1929.
   PubMed Web of Science ®Google Scholar
• Tong L, Chaurasia SS, Mehta JS, Beuerman RW. Screening for meibomian gland disease: Its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Invest Ophthalmol Vis Sci 2010;51:3449–3454.
   PubMed Web of Science ®Google Scholar
• Goto E, Monden Y, Takano Y et al. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol 2002;86:1403–1407.
   PubMed Web of Science ®Google Scholar
• Lemp MA, Baudouin C, Baum J et al. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surf 2007;5:75–92.
   PubMed Web of Science ®Google Scholar
• Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ. Nonobvious obstructive meibomian gland dysfunction. Cornea 2010;29:1333–1345.
   Web of Science ®Google Scholar
• Mori A, Oguchi Y, Goto E et al. Efficacy and safety of infrared warming of the eyelids. Cornea 1999;18:188–193.
   Web of Science ®Google Scholar
• Mori A, Shimazaki J, Shimmura S, Fujishima H, Oguchi Y, Tsubota K. Disposable eyelid-warming device for the treatment of meibomian gland dysfunction. Jpn J Ophthalmol 2003;47:578–586.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Dogru M, Goto E et al. Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea 2006;25:644–650.
   PubMed Web of Science ®Google Scholar
• Fuller JR. Therapeutic eye and eyelid cover. US Patent application publication. US Patent 2004/0237969 A1. December 2, 2004.
   Google Scholar
• Mitra M, Menon GJ, Casini A et al. Tear film lipid layer thickness and ocular comfort after meibomian therapy via latent heat with a novel device in normal subjects. Eye (Lond) 2005;19:657–660.
   PubMed Web of Science ®Google Scholar
• Di Pascuale MA, Liu TS, Trattler W, Tseng SC. Lipid tear deficiency in persistent dry eye after laser in situ keratomileusis and treatment results of new eye-warming device. J Cataract Refract Surg 2005;31:1741–1749.
   Google Scholar
• Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. Adv Exp Med Biol 1994;350:293–298.
   PubMedGoogle Scholar
• Blackie CA, Solomon JD, Greiner JV, Holmes M, Korb DR. Inner eyelid surface temperature as a function of warm compress methodology. Optom Vis Sci 2008;85:675–683.
   PubMed Web of Science ®Google Scholar
• Despa F, Orgill DP, Neuwalder J, Lee RC. The relative thermal stability of tissue macromolecules and cellular structure in burn injury. Burns 2005;31:568–577.
   PubMed Web of Science ®Google Scholar
• Korb DR, Blackie CA. Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case report. Cornea 2010;29:930–933.
   Web of Science ®Google Scholar
• Friedland BR, Fleming CP, Blackie CA, Korb DR. A novel thermodynamic treatment for meibomian gland dysfunction. Curr Eye Res 2011;36:79–87.
   Web of Science ®Google Scholar
• Terada O, Chiba K, Senoo T, Obara Y. [Ocular surface temperature of meibomian gland dysfunction patients and the melting point of meibomian gland secretions]. Nippon Ganka Gakkai Zasshi 2004;108:690–693.
   PubMedGoogle Scholar
• Huang HW, Shih TC, Liauh CT. Predicting effects of blood flow rate and size of vessels in a vasculature on hyperthermia treatments using computer simulation. Biomed Eng Online 2010;9:18.
   PubMedGoogle Scholar
• Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003;29:96–99.
   PubMedGoogle Scholar
• Korb DR, Baron DF, Herman JP et al. Tear film lipid layer thickness as a function of blinking. Cornea 1994;13:354–359.
   PubMed Web of Science ®Google Scholar
• Geerling G, Tauber J, Baudouin C et al. The international workshop on meibomian gland dysfunction: Report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011;52:2050–2064.
   PubMed Web of Science ®Google Scholar
• Lane S, LipiFlow® Study Group. A new system, the LipiFlow®, for the treatment of meibomian gland dysfunction (MGD). Cornea. (In Press).
   Google Scholar
• Korb DR, Herman JP, Greiner JV et al. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens 2005;31:2–8.
   PubMedGoogle Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615–621.
   PubMed Web of Science ®Google Scholar
• Korb DR, Greiner JV, Herman J. Comparison of fluorescein break-up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) method. Cornea 2001;20:811–815.
   PubMed Web of Science ®Google Scholar
• Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: Correlation with dry eye symptoms and gland location. Cornea 2008;27:1142–1147.
   PubMed Web of Science ®Google Scholar
• Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW. Topical azithromycin therapy for meibomian gland dysfunction: Clinical response and lipid alterations. Cornea 2010;29:781–788.
   PubMed Web of Science ®Google Scholar
• Avni I, Garzozi HJ, Barequet IS et al. Treatment of dry eye syndrome with orally administered CF101: Data from a phase 2 clinical trial. Ophthalmology 2010;117:1287–1293.
   PubMed Web of Science ®Google Scholar
• Utine CA, Stern M, Akpek EK. Clinical review: Topical ophthalmic use of cyclosporin A. Ocul Immunol Inflamm 2010;18:352–361.
   PubMed Web of Science ®Google Scholar
• Dogru M, Tsubota K. Pharmacotherapy of dry eye. Expert Opin Pharmacother 2011;12:325–334.
   PubMed Web of Science ®Google Scholar
• Asbell PA. Increasing importance of dry eye syndrome and the ideal artificial tear: Consensus views from a roundtable discussion. Curr Med Res Opin 2006;22:2149–2157.
   PubMed Web of Science ®Google Scholar
• Nelson JD, Helms H, Fiscella R, Southwell Y, Hirsch JD. A new look at dry eye disease and its treatment. Adv Ther 2000;17:84–93.
   PubMed Web of Science ®Google Scholar